Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021:1325:103-116.
doi: 10.1007/978-3-030-70115-4_4.

Glycosaminoglycans

Yuefan Song  1   2 , Fuming Zhang  3 , Robert J Linhardt  4
Affiliations

Glycosaminoglycans

Yuefan Song et al. Adv Exp Med Biol. 2021.

Abstract

Glycosaminoglycans (GAGs) are important constituents of human glycome. They are negatively charged unbranched polysaccharides that are usually covalently attached to proteins, forming glycan-protein conjugates, called proteoglycans. Glycosaminoglycans play critical roles in numerous biological processes throughout individual development and are also involved in the pathological processes of various diseases. Based on their remarkable bioactivities and their universal involvement in disease progression, GAGs are applied as therapeutics or are being targeted or used in treating diseases. In this chapter, we introduce the characteristics of the four classes of GAGs that constitute the glycosaminoglycan family. The pathological roles of glycosaminoglycans in major diseases including innate disease, infectious disease, and cancer are discussed. The application of GAGs and their mimetics as therapeutics is introduced, as well as those therapeutic methods developed based on GAGs' role in pathogenesis. In addition, we provide a brief and overall lookback at the history of GAG research and sort out some critical techniques that facilitated GAG and glycomics studies.

Keywords: Cancer; Glycomics; Glycosaminoglycans; Heparin; Infectious disease; Innate disease.

PubMed Disclaimer

References

    1. Afratis N, Gialeli C, Nikitovic D, Tsegenidis T, Karousou E, Theocharis AD, Pavão MS, Tzanakakis GN, Karamanos NK (2012) Glycosaminoglycans: key players in cancer cell biology and treatment. FEBS J 279(7):1177–1197. https://doi.org/10.1111/j.1742-4658.2012.08529.x - DOI - PubMed
    1. Aquino RS, Park PW (2016) Glycosaminoglycans and infection. Front Biosci (Landmark Ed) 21:1260–1277. https://doi.org/10.2741/4455 - DOI
    1. Aquino RS, Lee ES, Park PW (2010) Diverse functions of glycosaminoglycans in infectious diseases. In: Progress in molecular biology and translational science, vol 93. Elsevier, pp 373–394
    1. Ariga T, Miyatake T, Yu RK (2010) Role of proteoglycans and glycosaminoglycans in the pathogenesis of Alzheimer’s disease and related disorders: Amyloidogenesis and therapeutic strategies – a review. J Neurosci Res 88(11):2303–2315
    1. Belting M (2014) Glycosaminoglycans in cancer treatment. Thromb Res 133:S95–S101. https://doi.org/10.1016/S0049-3848(14)50016-3 - DOI - PubMed

LinkOut - more resources